This inventor holds 1 USPTO granted patent. Top assignee: Universite Laval, Cite Universitaire. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Francedillaois Rousseau: Innovator in Osteoporosis Research
Introduction
Francedillaois Rousseau is a notable inventor based in Ste-Foy, Canada. He has made significant contributions to the field of osteoporosis research through his innovative patent. His work focuses on understanding the genetic factors that influence bone mineral density.
Latest Patents
Rousseau holds a patent titled "Marker at the estrogen receptor gene for determination of osteoporosis." This invention relates to a method for determining a patient's predisposition to low or high bone mineral density and the development of osteoporosis. The method involves assessing estrogen receptor polymorphism in a biological sample, where heterozygosity is linked to high bone density and homozygosity to low bone density. He has 1 patent to his name.
Career Highlights
Francedillaois Rousseau is affiliated with Université Laval, located in the Cité Universitaire. His role at this esteemed institution allows him to engage in cutting-edge research and contribute to advancements in medical science.
Conclusion
Francedillaois Rousseau's work in osteoporosis research exemplifies the impact of innovative thinking in the medical field. His patent highlights the importance of genetic factors in bone health, paving the way for future research and potential treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile